Breaking News

Asymchem Leverages AI to Optimize Protein Design with STAR Platform

Creates an artificial intelligence platform to address key challenges in protein design.

Author Image

By: Charlie Sternberg

Associate Editor

Asymchem, a global contract development and manufacturing organization (CDMO), has created an artificial intelligence (AI) platform to address key challenges in protein design. This platform, known as STAR (Sequence Recommendation via Artificial Intelligence), was developed by Asymchem’s Center of Synthetic Biology Technology (CSBT) and AI team.   A significant hurdle in protein engineering is the volume of mutations that must be generated and tested, a process that can last from 3 to 6 months...

Continue reading this story and get 24/7 access to Contract Pharma for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters